What Is Thymosin Alpha-1? A Research Overview

Thymosin alpha-1 (Tα1) is a 28-amino-acid thymic peptide studied in immune-signaling and immune-modulation research. The material discussed here is supplied strictly for controlled in-vitro laboratory research by qualified professionals. It is not a finished pharmaceutical product and is not for human or veterinary use.

Quick facts

• Class: thymic immune-signaling peptide (28 amino acids)
• Research focus: immune-modulation research (T-cell and dendritic-cell signaling)
• Form: lyophilized powder for laboratory research use only
• Status: research use only — not for human consumption

What is Thymosin Alpha-1?

Thymosin alpha-1 is a defined 28-amino-acid sequence originally isolated from thymosin fraction 5. Its compact sequence makes it a reference compound in laboratory immunology and receptor-signaling research. This article addresses that analytical research context only.

What does the research show?

Published preclinical and controlled-study literature examines Tα1 as an immune-signaling research compound [1][2]. These citations are included to document the scientific record and study models, not to provide a route, amount, protocol, or claim for any Bolt material.

Mechanisms studied in the lab

• T-cell signaling: studied for association with maturation and differentiation of T lymphocytes and a shift toward Th1-type responses.
• Dendritic-cell activation: investigated for priming dendritic cells and modulating antigen presentation [3].
• Toll-like receptor (TLR) pathways: reported to engage TLR signaling (e.g., TLR9), with downstream effects on cytokine production [3].

Research status and safety

The Tα1 offered here is a research-use-only material for in-vitro and laboratory study by qualified researchers. It is not a dietary supplement, drug, or medical product, and is not intended to diagnose, treat, cure, or prevent any disease. Although a thymosin-alpha-1 pharmaceutical exists and is approved in some jurisdictions, that approval does not extend to this research material.

Handling

Thymosin alpha-1 is supplied in lyophilized form. Qualified laboratory personnel must establish storage, solvent compatibility, material handling, and final concentration under an approved protocol and SOP. See the laboratory concentration and handling reference, browse the research catalog, or review Thymosin Alpha-1 product details.

FAQ

Is this a finished commercial product? No. Bolt Peptide supplies a research-use-only reference material for controlled laboratory work.

How many amino acids does Thymosin alpha-1 contain? It is a 28-amino-acid peptide, a relatively small and well-characterized molecule for immunology research.

What is the intended context for this material? Controlled in-vitro laboratory research by qualified professionals only. It is not for human or veterinary use.

References

1. Wu J, et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): an RCT. Critical Care. 2013.
2. Tao N, et al. Thymosin alpha1 and Its Role in Viral Infectious Diseases. Molecules. 2023.
3. Romani L, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism. Blood. 2006.

For research use only. Not for human or veterinary use. The research material is not the approved medicine. Statements have not been evaluated by the FDA.